Menu

Investors

SEC Filings

SEC Filings

Filing date Form Description View
May 9, 2019 DEFA14A

Additional proxy soliciting materials - definitive

View HTML
May 9, 2019 3

Initial filing by director officer or owner of more than ten percent.

View HTML
May 9, 2019 10-Q

Quarterly report which provides a continuing view of a company's financial position

EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
April 30, 2019 CT ORDER

CT ORDER

View HTML
April 26, 2019 DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

View HTML
April 26, 2019 DEFA14A

Additional proxy soliciting materials - definitive

View HTML
April 18, 2019 8-K

Report of unscheduled material events or corporate event

View HTML
April 12, 2019 4

Statement of changes in beneficial ownership of securities

View HTML
April 12, 2019 4

Statement of changes in beneficial ownership of securities

View HTML
April 12, 2019 4

Statement of changes in beneficial ownership of securities

View HTML

Copyright Morningstar

Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us